Relic Biotechnology Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-07-2024
- Paid Up Capital ₹ 0.10 M
as on 12-07-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 25.89%
(FY 2022)
- Profit 20.20%
(FY 2022)
- Ebitda 243.85%
(FY 2022)
- Net Worth 8.09%
(FY 2022)
- Total Assets 9.90%
(FY 2022)
About Relic Biotechnology
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Tejraj Patel and Suvendu Patel serve as directors at the Company.
- CIN/LLPIN
U01110PN2010PTC135294
- Company No.
135294
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Relic Biotechnology Private Limited offer?
Relic Biotechnology Private Limited offers a wide range of products and services, including Personal Care, Oral Care.
Who are the key members and board of directors at Relic Biotechnology?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suvendu Patel  | Director | 11-Jan-2010 | Current |
| Tejraj Patel | Director | 11-Jan-2010 | Current |
Financial Performance of Relic Biotechnology.
Relic Biotechnology Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.89% increase. The company also saw a substantial improvement in profitability, with a 20.2% increase in profit. The company's net worth moved up by a moderate rise of 8.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Relic Biotechnology?
In 2021, Relic Biotechnology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Relic Biotechnology?
Unlock and access historical data on people associated with Relic Biotechnology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Relic Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relic Biotechnology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
